DiagnaMed Holdings Corp. (TSE:DMED)
CNQX:DMED
Canadian Market
Holding TSE:DMED?
Track your performance easily

DiagnaMed Holdings Corp. (DMED) Income Statement

6 Followers

DiagnaMed Holdings Corp. Income Statement

Last quarter (Q3 2024), DiagnaMed Holdings Corp.'s total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, DiagnaMed Holdings Corp.'s net income was C$-220.62K. See DiagnaMed Holdings Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 23Sep 22Sep 21
Total Revenue
---C$ 0.00
Cost of Revenue
----
Gross Profit
----
Operating Expense
C$ 977.41KC$ 1.14MC$ 1.14MC$ 683.67K
Operating Income
C$ -977.41KC$ -1.14MC$ -1.14MC$ -683.67K
Net Non Operating Interest Income Expense
C$ -8.87K---
Other Income Expense
C$ -29.07KC$ 75.25KC$ 3.26KC$ -1.26M
Pretax Income
C$ -954.64KC$ -1.13MC$ -1.13MC$ -1.95M
Tax Provision
----
Earnings From Equity Interest Net Of Tax
C$ -52.87KC$ -75.25K--
Net Income Common Stockholders
C$ -954.64KC$ -1.13MC$ -1.13MC$ -1.95M
Basic EPS
-C$ -0.01C$ -0.01C$ -0.03
Diluted EPS
-C$ -0.01C$ -0.01C$ -0.03
Basic Average Shares
C$ 316.41MC$ 76.06MC$ 76.06MC$ 76.22M
Diluted Average Shares
C$ 316.41MC$ 76.06MC$ 76.06MC$ 76.22M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
C$ 977.41KC$ 1.14MC$ 1.14MC$ 683.67K
Net Income From Continuing And Discontinued Operation
C$ -954.64KC$ -1.13MC$ -1.13MC$ -1.95M
Normalized Income
C$ -961.17KC$ -832.34KC$ -832.34KC$ -683.67K
Interest Expense
----
EBIT
C$ -903.19KC$ -1.13MC$ -1.13MC$ -683.67K
EBITDA
C$ -903.19KC$ -1.13MC$ -1.13MC$ -683.67K
Currency in CAD

DiagnaMed Holdings Corp. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis